1
0
0
News
Doravirine HIV treatment resulted in fewer adverse events
www.healio.com
The use of once-daily oral doravirine plus tenofovir/emtricitabine resulted in fewer adverse events in patients with HIV-1 compared with efavirenz plus...
Merck HIV therapies make big news at CROI | Drug Discovery News
www.drugdiscoverynews.com
Company gives a peek at a new drug and shares a study for an old
favorite
Netzwerk-Profile
WikiGenes - Hedy Teppler
www.wikigenes.org
Long-term safety from the raltegravir clinical development program. Teppler, H., Brown, D.D., Leavitt, R.Y., Sklar, P., Wan, H., Xu, X., Lievano, F., Lehman, H.P., ...
Interessen
Lancet Infectious Diseases, The - Vol n° 7 - EM consulte
www.em-consulte.com
... Adriano Lazzarin, Jeffrey L Lennox, Kim M Strohmaier, Hong Wan, Richard JO Barnard, Bach-Yen T Nguyen, Hedy Teppler, for the BENCHMRK Study Teams.
Bücher
PLOS ONE: Raltegravir Non-Inferior to Nucleoside Based Regimens in...
journals.plos.org
Hedy Teppler is employed by Merck Research Laboratories, and owns stocks and shares in the company. Boris Renjifo is employed by Abbvie ...
Table of Contents: Atlas of AIDS /
library.villanova.edu
Host Response /; Deshratn Asthana, Margaret A. Fischl and Hedy Teppler /; [et al.] Ch. 4. Classification and Spectrum /; Gregory J. Dore and David A. Cooper ...
Atlas of AIDS - Google Books
books.google.de
There probably is no field of medicine that moves as tions of recently reported information and inclusion rapidly as does HIV / AIDS. New basic discoveries,...
XI Reunión de medicina interna y otros temas - Fernando Marcos...
books.google.de
Se presentan 10 ponencias presentadas en la XI Reunión de Medicina Interna de Talavera de la Reina, celebrada el 17 de Octubre de Las comunicaciones han...
Dokumente zum Namen
Echinocandins in the ICU
de.slideshare.net
Overview of candidiasis, antifungal pharmacology and the role of echinocandins
Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal...
www.proquest.com
Thomas J. Walsh, M.D., Hedy Teppler, M.D., Gerald R. Donowitz, M.D., Johan A. Maertens, M.D.,. Lindsey R. Baden, M.D., Anna Dmoszynska, ...
EBSCOhost | | Long-term Treatment With Raltegravir or...
web.b.ebscohost.com
Monica L. Walker,6 Xia Xu,6 Jing Zhao,6 Hedy Teppler,6 Mark J. DiNubile,6 Anthony J. Rodgers,6 Bach-Yen Nguyen,6. Randi Leavitt,6 and Peter Sklar6 for the ...
Doravirine - Virology Education
regist2.virology-education.com
Iwamoto, Xia Xu, Hedy Teppler, Sauzanne Khalilieh are current employees of Merck & Co., Inc., Kenilworth, NJ, USA. • Patrice Auger, Charles ...
Wissenschaftliche Veröffentlichungen
International Journal of Antimicrobial Agents | Vol 20, Issue 3,...
www.sciencedirect.com
Original research article: Pages Albert E Yellin, James M Hassett, Alvaro Fernandez, James Geib, ... Hedy Teppler. Download PDF. Article preview ...
Veröffentlichungen allgemein
Ertapenem Once a Day Versus Piperacillin–Tazobactam Every 6 Hours...
www.hindawi.com
View at Publisher · View at Google Scholar; Richard M. Gesser, Kathleen McCarroll, Hedy Teppler, and Gail L. Woods, “Efficacy of ertapenem in the treatment of ...
Sonstiges
Dr. Hedy Teppler (center, foreground) and her research team at Thomas...
www.pinterest.de
Discover ideas about Philadelphia Inquirer. Dr. Hedy Teppler (center, foreground) and her research team at Thomas Jefferson hospital in Philadelphia, PA
AIDS Vancouver, BC Abstract TUAB0104 Efficacy and Safety of...
slideplayer.com
AIDS Vancouver, BC Abstract TUAB Disclosures Dr. Gatell has received research grants or honoraria for lectures or for Advisory Boards from MSD, Abbvie,...
Hedy Teppler - Internal Medicine, Infectious Disease - Blue Bell - PA...
careon.me
Hedy Teppler - Internal Medicine, Infectious Disease - Blue Bell - PA
Hedy Teppler - Infectious Disease, Infectious Diseases - Blue Bell -...
careon.me
Hedy Teppler - Infectious Disease, Infectious Diseases - Blue Bell - PA
Ausgewählte Berichte und Publikationen - IFI Medizin
www.ifi-medizin.de
... Christian Hoffmann, Keikawus Arasteh, Melanie Thompson, Debbie P. Hagins, Javier O. Morales-Ramirez, Xia Xu, Hedy Teppler for the P007 Study Team: ...
Hyman R Kahn - Internal Medicine, Cardiovascular Diseases - Blue Bell...
careon.me
Hyman R Kahn - Internal Medicine, Cardiovascular Diseases - Blue Bell - PA
8 years and $700 million later, how a better drug was found
www.inquirer.com
The young biochemist tried to contain her excitement as she peered through the microscope in her cramped laboratory. The AIDS virus that she had disabled was...
Abstract: Safety, Tolerability, and Antiretroviral Activity of...
idsa.confex.com
Hedy Teppler, MD1, Andrey Shuldyakov, MD2, Natalia Gankina, PhD3, Valeriy Kulagin, PhD4, Firaya Nagimova, PhD5, Tatiana Shimonova, ...
Altmetric – Antiretroviral Activity, Pharmacokinetics, and...
www.altmetric.com
... M Kovacs, Roy T Steigbigel, David A Cooper, Ralph Liporace, Robert Schwartz, Robin Isaacs, Lucinda R Gilde, Larissa Wenning, Jing Zhao, Hedy Teppler.
Doravirina, de MSD, reduce los efectos adversos al tratamiento en...
www.redaccionmedica.com
La compañía espera iniciar pronto los estudios en fase III con este producto
Doravirine (MK-1439): A Novel HIV-1 NNRTI With a Distinct Resistance...
www.natap.org
Ming-Tain Lai,1 Meizhen Feng,1 Nancy Sachs,2 Min Xu,2 Jay Grobler,1 Xia Xu,3 Charlotte Harvey,4 Hedy Teppler,4 Daria J. Hazuda,1 Michael D. Miller1 ...
Merck Announces Positive Results From Phase 2b HIV Combo Therapy Study
www.outsourcedpharma.com
Merck has announced data from a 48-week Phase 2b clinical trial that evaluated the safety and efficacy of once daily oral doravirine plus...
Merck Posts Phase 2B Results of HIV Drug Doravirine
www.bioprocessonline.com
Dr. Hedy Teppler, executive director of Infectious Diseases at Merck Research Laboratories, said that the company will continue to study and ...
Merck: FDA Has Approved Pediatric Version of HIV Therapy
www.wallstwatchdog.com
Merck announced Wednesday that a pediatric version of the HIV therapy medication ISENTRESS has been approved by the U.S. Food and Drug Administration.
Long-term safety from the raltegravir clinical development program -...
pubmed.ncbi.nlm.nih.gov
Long-term data from the phase III clinical trials demonstrate that raltegravir was generally well-tolerated in both treatment-naïve and treatment-experienced...
Pharmacokinetics, safety, and 48-week efficacy of oral raltegravir in...
jhu.pure.elsevier.com
Sharon Nachman ; Nan Zheng ; Edward P. Acosta ; Hedy Teppler ; Brenda Homony ; Bobbie Graham ; Terence Fenton ; Xia Xu ; Larissa Wenning ; Stephen A.
Raltegravir non-inferior to nucleoside based regimens in second-line...
researchers.mq.edu.au
... Mohapi, Stephen J. Kerr, Annette H. Sohn, Hedy Teppler, Boris Renjifo, Jean Michel Molina, Sean Emery, David A. Cooper, SECOND-LINE.
Weiser, US - Patent applications
www.patentsencyclopedia.com
Hedy Teppler Weiser, Merion, PA US. Patent application number, Description, Published , TASTE-MASKED FORMULATIONS OF RALTEGRAVIR ...
FDA OKs Oral Isentress to Treat HIV in Children - POZ
www.poz.com
... that Isentress can now be a part of a treatment regimen for HIV-1 infected infants and children as young as four weeks of age,” Hedy Teppler, ...
Verwandte Suchanfragen zu Hedy Teppler
| Larissa Wenning Sean Emery Bryan Black |
Personen Vorname "Hedy" (328) Name "Teppler" (34) |
sortiert nach Relevanz / Datum